Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...

Researchers conducted a retrospective study published in June 2025 issue of Rheumatology International to compile evidence on sex-specific differences in systemic lupus erythematosus (SLE), focusing ...

Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...

This year, the Lupus Foundation of America (LFA) is pleased to announce two recipients of grants supporting pediatric lupus research. This year’s recipients are Nayimisha Balmuri, MD, Assistant ...

Lupus nephritis articles from across Nature Portfolio Lupus nephritis is an inflammatory kidney disease (glomerulonephritis) that develops in patients with systemic lupus erythematosus (SLE).

The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

A lupus diagnosis can profoundly affect many aspects of a man’s life, from sense of identity and mental health to the way one engages with loved ones and the broader community. While lupus is often ...

Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus nephritis is treated in children, ...

Chronic exposure to the systemic inflammation caused by the autoimmune disease may explain the associations found, say the researchers.

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...